Irving, Texas-based Reata Pharmaceuticals, a biotech working on new drugs to treat cancer and inflammation, raised $25 million in a fifth funding round. The round was led by existing investors, including CPMG and Novo A/S.
Posts Tagged ‘co:Reata-Pharmaceuticals’
Top Stories
- Panasonic swallows the 3-D hook
- Report: Facebook growing, rivals shrinking in U.S.
- Intel writes off $950M on Clearwire investment
- Newsflash: Apple has been charging for iTunes ...
- If the New York Times dies, does ...
Recent Guest Columnists
Job Board
- Web developer for online gaming service provider
at Betzya (London, but remote working possible) - More Jobs » | Post a Job »
Links
Venturebeat Writers
- Matt Marshall, Editor-in-Chief
- Dean Takahashi, Lead Writer, DigitalMedia
- Eric Eldon, Editor, DigitalMedia
- MG Siegler, Writer, DigitalMedia
- Anthony Ha, Writer, VentureBeat
- Chris Morrison, Writer, CleanTech
- For advertising, contact .
- Log in
Font Size
© 2004-2009(c) Matt Marshall. All rights reserved.Site produced by RubyRed Labs, Evan Levelle
powered by Wordpress